COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04390763
Brief Title: Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

First Submitted : May 14, 2020
First Submitted that Met QC Criteria : May 14, 2020
First Posted : May 18, 2020

Last Update Submitted that Met QC Criteria : December 14, 2020
Last Update Posted : December 16, 2020